Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03131388 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of AMH Assay
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 277
- Enrollment target
NCT03131388 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 277 participants.
The verdict
NCT03131388 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
Study Summary
The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.
Interventions
- DIAGNOSTIC_TEST Access AMH Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03131388
The ClinicalTrials.gov registry entry for NCT03131388 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Access AMH Assay is the first listed.
NCT03131388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03131388 about?
NCT03131388 is a clinical study titled "Clinical Performance Evaluation of AMH Assay". The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.
What is the current status of trial NCT03131388?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2016-09. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03131388?
The interventions under investigation include: Access AMH Assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03131388?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.